Delivery Order SPE2DB20D3104-SPE2DB25FV9N8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.17 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $1,925.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on April 22, 2025, with completion targeted for April 23, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $2,117.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency (DLA) awarded a $1,713.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This competitively awarded, non-set-aside contract features firm fixed pricing and a delivery completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL with a ceiling value of $1,022.57. This firm fixed-price delivery order, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.04 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, a hormone replacement therapy medication. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-competed award under the company's existing contract vehicle. Performance will be fulfilled from AmerisourceBergen's corporate office location in...
- This delivery order, awarded August 29, 2025, grants AmerisourceBergen Drug Corp a $1,449.00 firm fixed price contract for Testosterone Cypionate 200 mg/mL, with completion scheduled for September 2, 2025. The award was issued by the Defense Logistics Agency under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on September 13, 2025, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order is performed at the contractor's Conshohocken, Pennsylvania location and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award is issued...
- This delivery order, valued at $1,416.00, was awarded to AmerisourceBergen Drug Corp on August 5, 2025, by the Defense Logistics Agency (DLA) for the supply of Testosterone Cypionate 200 mg/mL. The contract is a firm fixed-price delivery order with performance scheduled to conclude on August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside designation was applied to this competitive...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9N8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.36 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. This delivery order for testosterone cypionate represents one of numerous pharmaceutical and medical supply transactions executed under the parent contract vehicle, demonstrating the company's ongoing capability to meet federal healthcare supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/14/25 |